KACTUS has developed a series of high-activity enzyme for in vitro synthesis of DNA vectors, based on their SAMS™ technology platform.
KACTUS: DNA Synthesis Enzymes
KACTUS: RNA Synthesis Enzymes
KACTUS have used their SAMS™ protein production platform to develop high-quality enzymes for in vitro synthesis of mRNA (GMP-Grade & GMP-Ready).
KACTUS: Endonuclease – MaxNuclease™ GMP-Grade
KACTUS has developed a GMP-grade universal nuclease – MaxNuclease™, which degrades all DNA and RNA into 2-5 base oligonucleotides.
KACTUS: CRISPR Cas9 Protein
At KACTUS, they have developed a highly-active, wild-type Cas9 nuclease based on their SAMS™ technology platform.
KACTUS: AccuBase® Base Editor
AccuBase® is a cytosine base editor that converts a C-G base pair into a T-A base pair in the genome. Designed by Base Therapeutics, manufactured by KACTUS.
KACTUS: CAR-T Target Antigens
KACTUS has developed a series of high-quality CAR-T target protein products, covering a wide range of popular targets such as CD19, BCMA, and MSLN.
KACTUS: HLA-G & LILR Proteins
At KACTUS, they offer a comprehensive range of high-quality recombinant HLA-G and LILR proteins, to support research and development in immunology and therapeutic applications.
KACTUS: Transmembrane Proteins
KACTUS has developed two transmembrane protein display platforms: virus-like particles (VLPs) and nanodiscs.
KACTUS: Immune Checkpoint Proteins
KACTUS have developed a series of immune checkpoint proteins with various tags.
KACTUS: Cytokines & Receptors
KACTUS has developed a full portfolio of tag-free or small-tag cytokines with verified cellular-level bioactivity for various cell culture applications.